Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Epigenetic regulation of astrocyte-specific NLRP6 inflammasome and PANoptosis in HIV Tat and methamphetamine-mediated neuroinflammation

Award Number: R01DA060753
ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 04/30/2029

Group Awards By:

View Award Description

Epigenetic regulation of astrocyte-specific NLRP6 inflammasome and PANoptosis in HIV Tat and methamphetamine-mediated neuroinflammation - Project Summary: According to the Centers for Disease Control and Prevention, HIV infection and drug abuse are intertwined epidemics that limit adherence to combination antiretroviral therapy (cART) and contribute to the worsening of HIV-associated neurocognitive disorders referred to as NeuroHIV. Despite the ability of cART to significantly decrease viremia, the brain remains a reservoir of low-level HIV replication with the accumulation and persistence of cytotoxic viral proteins, including the HIV Transactivator of transcription (Tat). Methamphetamine is a highly addictive synthetic stimulant commonly abused by HIV-infected people worldwide. It is generally established that HIV/HIV proteins and methamphetamine activate inflammasomes in central nervous system cells, particularly microglia. However, there is a knowledge gap in our understanding of how HIV/HIV proteins and methamphetamine contribute to activating astrocyte-specific inflammasomes – NLRP6, leading to neuroinflammation, which is the focus of this study. The long-term goal is to identify the molecular mechanism(s) involved in HIV and methamphetamine-mediated astrocyte activation, which can set the stage for developing novel therapeutic targets to alleviate neuroinflammation associated with NeuroHIV. This proposal uses in vitro, ex vivo, and in vivo approaches to identify the molecular mechanism(s) involved in HIV Tat and methamphetamine-mediated astrocyte-specific NLRP6 inflammasome and its role in PANoptosis-mediated neuroinflammation. The central hypothesis is that HIV Tat-mediated astrocyte activation and neuroinflammation in NeuroHIV involve ZBP1/NLRP6-mediated PANoptosis. The hypothesis will be tested with two specific aims, and the outcome of this study will set the stage for developing novel therapeutics to dampen HIV and drug abuse- mediated neuroinflammation in NeuroHIV. Overall, this R01 application aims to determine how exposure to HIV Tat and methamphetamine induces the astrocyte-specific inflammasome, NLRP6, and its role in PANoptosis- mediated neuroinflammation using in vitro, ex vivo, and in vivo approaches.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $509,793 )
2026	2026	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	4215 EMILE ST	OMAHA	NE	68105	DOUGLAS	USA	Drug Use and Addiction Research Programs	000	3	4/28/2026	NON-COMPETING CONTINUATION	$509,793
														Subtotal = $509,793

Issue Date FY: 2025 ( Subtotal = $509,793 )
2025	2025	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	4215 EMILE ST	OMAHA	NE	68105	DOUGLAS	USA	Drug Use and Addiction Research Programs	000	2	4/11/2025	NON-COMPETING CONTINUATION	$509,793
														Subtotal = $509,793

Issue Date FY: 2024 ( Subtotal = $513,978 )
2024	2024	BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA	987835 NEBRASKA MEDICAL CENTER	OMAHA	NE	68198	DOUGLAS	USA	Drug Use and Addiction Research Programs	000	1	6/25/2024	NEW	$513,978
														Subtotal = $513,978

Grand Total All Awards = $1,533,564

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Epigenetic regulation of astrocyte-specific NLRP6 inflammasome and PANoptosis in HIV Tat and methamphetamine-mediated neuroinflammation

Award Number: R01DA060753

ORGANIZATION: NATIONAL INSTITUTE ON DRUG ABUSE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 04/30/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer